Prostate Cancer Therapeutics Drugs Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Size, Share & Trends, Drivers, Restraints, Opportunities, Manufacturer, Applications, And Segments

  • AMR-1063382
  • May 2021
  • Pharmaceuticals
  • 123 Pages
The global Prostate Cancer Therapeutics Drugs market research report provides complete study and detail analysis of the market. This study includes forecast analysis of the market which is based on global and regional level, whereas the research reports the provides forecast data from 2020-2028 and historic of 2018 and 2019. All the values are based on revenue USD Million. Moreover, the market research report describes various segments of the Prostate Cancer Therapeutics Drugs market based on its types, applications and end-use industry. The applications of the market are explained in different industry verticals with reference to major countries across the globe. Along with this, the research report also covers all the major players that are operating in the global Prostate Cancer Therapeutics Drugs market. These major players of the market are further studied and analyzed based on various parameters, such as annual market revenue, annual sales of the company, marketing strategy, historic growth and shipment volumes. Based on all the company’s insights, the market research analyst also suggests business strategy and marketing plans for improving the market position of existing participants of Prostate Cancer Therapeutics Drugs market.
 
Report Parameters Details of Parameter
Market Size xx Million
Based Year 2020
Forecast Period Covered 2020 – 2028
Units for value Revenue in USD million and CAGR from 2020 to 2028
Covered Segments Component, Types, Applications, End-Users, and more.
Companies Covered JOHNSON AND JOHNSON, ASTELLA, INC., SANOFI, IPSEN, BAYER AG, ASTRAZENECA, VALEANT PHARMACEUTICALS NORTH AMERICA LLC (DENDREON CORPORATION), TOLMAR INC, ENDO PHARMACEUTICALS, ABBVIE, INC., BDR Pharma, CADILA HEALTHCARE, DR. REDDY\'S LABORATORIES, PFIZER, ASTELLAS PHARMA
Region Covered North America, Europe, Asia Pacific, Latin America, Middle East and Africa

COVID-19 Impact Analysis
The analysis of covid-19 is based on the impact of the current pandemic situation on market scenarios. This includes impact of covid-19 outbreak on overall revenue, market segments as well as regional market. The report also puts light on detailed impact analysis by taking into consideration all the government policies imposed during the pandemic situation, temporary shutdown of manufacturing units, current state of supply chain and distributors, and its future impacts on the growth of overall market. The market study will assist user to understand the global demand and impose strategic business plans to compete with the peers.

Apart from this, the market research report also covers drivers and restraints for the global Prostate Cancer Therapeutics Drugs market and their impact on the demand and supply during the forecast period. Along with this, the research report also provides Prostate Cancer Therapeutics Drugs market trends and opportunities that are based on regional and global level. Furthermore, the market research report also provides the major distributors and manufacturers that are operating in all the key region across the world. The researched data provided in the report is widely used by various industry players to strengthen their distribution channel and improve the geographical reach. In addition, the report also covers all the major players of the global Prostate Cancer Therapeutics Drugs market and its key offerings and solutions. The report also provides recent mergers and acquisitions of these key players.

The data which is provided in the market research report is analyzed and evaluated with the help of various marketing tools, such as SWOT analysis, Poster’s Five Force analysis, PESTEL analysis, value chain analysis, player positioning analysis and market share analysis. Therefore, this analysis tools helps the analyst to evaluate the Prostate Cancer Therapeutics Drugs market based on various parameters such as capital investments, impact of consumer’s preferences, economies of scale, manufacturing rights and patents, existing distribution channels, switching costs, government regulations and brand loyalty.

Major Key Players for Global Prostate Cancer Therapeutics Drugs Market:
The Prostate Cancer Therapeutics Drugs market research report offers the company profile of major key players including progress trends, competitive landscape breakdown, and key in regions development status. JOHNSON AND JOHNSON, ASTELLA, INC., SANOFI, IPSEN, BAYER AG, ASTRAZENECA, VALEANT PHARMACEUTICALS NORTH AMERICA LLC (DENDREON CORPORATION), TOLMAR INC, ENDO PHARMACEUTICALS, ABBVIE, INC., BDR Pharma, CADILA HEALTHCARE, DR. REDDY\'S LABORATORIES, PFIZER, ASTELLAS PHARMA

Prostate Cancer Therapeutics Drugs Market Segment Analysis:
By Drug Class
Hormonal Therapy
Chemotherapy
Immunotherapy
Targeted Therapy
Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

Geographic Coverage for Prostate Cancer Therapeutics Drugs Market:
The market research report on global Prostate Cancer Therapeutics Drugs market offers complete analysis across various regions across the world. The Prostate Cancer Therapeutics Drugs market is distributed into various regions such as North America, Europe, Asia Pacific, Latin America and Middle East and Africa. The global leading market share as per the region is evaluated after considering Prostate Cancer Therapeutics Drugs market revenue, sales, shares, recent developments, innovations and growth rates. This section of regional analysis provides widespread evaluation of the industry from various countries and regions.

North America Prostate Cancer Therapeutics Drugs Market Value and Forecast
  • US
  • Canada
Europe Prostate Cancer Therapeutics Drugs Market Value and Forecast
  • UK
  • Germany
  • France
  •  Rest of Europe
Asia Pacific Prostate Cancer Therapeutics Drugs Market Value and Forecast
  • China
  • Japan
  • India
  • Rest of Asia Pacific
Latin America Prostate Cancer Therapeutics Drugs Market Value and Forecast
  • Mexico
  • Brazil
  • Rest of Latin America
Middle East and Africa Prostate Cancer Therapeutics Drugs Market Value and Forecast
  • GCC Countries
  • South Africa
  • Rest of Middle East and Africa


Key highlights of the Prostate Cancer Therapeutics Drugs market report:
  • The report provides key trends of the global Prostate Cancer Therapeutics Drugs market
  • The report also covers consumer preferences and current industry growth
  • Key products or solutions offered by the main players in the Prostate Cancer Therapeutics Drugs industry
  • The report covers all the recent developments of the Prostate Cancer Therapeutics Drugs market and helps to provide current industry updates
  • The report covers a detailed look over the global Prostate Cancer Therapeutics Drugs Industry and provides with significant actionable insights
  • The Prostate Cancer Therapeutics Drugs market estimation from 2020-2028 and historical data for 2018 and 2019
  • The market study also provides data on changing market dynamics, market intelligence, current and future market trends
  • The report also analyses the microeconomic and macroeconomic factors that are affecting the global Prostate Cancer Therapeutics Drugs market
  • In-depth analysis of the market’s competitive landscape and detailed information about the vendors
  • The report also offers key market drivers, restrains, trends and opportunities with present and future impact on the market
  • Detailed information about the major players or manufacturers of the global Prostate Cancer Therapeutics Drugs market
  • Comprehensive analysis of the Prostate Cancer Therapeutics Drugs market segments based on its types, applications and end-use industry
Key Analytical Areas:
The report aims to offer a complete solution to various businesses operating in the Prostate Cancer Therapeutics Drugs market in making strategic decisions based on credible information and actionable insights. Thereby, the report covers various aspects of your requirements such as industry overview, market dynamics, regional analysis and competitive landscape. The report aims to provide insights to businesses in the Prostate Cancer Therapeutics Drugs market for numerous purposes such as:

     1. Strategic Decision Making:
With the help of this report, key decision makers can quickly analyze and identify growth opportunities in terms of numerous segments across various geographical regions. Thereby, this report enables organizations to identify and make strategic investments in specific market segments in order to gain maximum return on investment.

      2.  Actionable Insights:
The report offers a deep dive into how companies are leveraging market conditions to make the most in the Prostate Cancer Therapeutics Drugs market. Thereby, the report offers numerous actionable insights into the best practices and key success factors relevant in the Prostate Cancer Therapeutics Drugs market. Using the insights included in the report, businesses can make quick decisions to achieve success in business operations.

      3. Competitive Snapshot:
In addition, to detailed information on the companies operating in the Prostate Cancer Therapeutics Drugs market, the report also includes a competitive snapshot of all the companies covered in the report. Thereby, this offers a visual representation of how all the companies stand comparatively based on their competencies, geographic presence, market hold, years of operations, employee and financial strength, among others.

Manufacturers and Segments

  • JOHNSON AND JOHNSON
  • ASTELLA, INC.
  • SANOFI
  • IPSEN
  • BAYER AG
  • ASTRAZENECA
  • VALEANT PHARMACEUTICALS NORTH AMERICA LLC (DENDREON CORPORATION)
  • TOLMAR INC
  • ENDO PHARMACEUTICALS
  • ABBVIE, INC.
  • BDR Pharma
  • CADILA HEALTHCARE
  • DR. REDDY'S LABORATORIES
  • PFIZER
  • ASTELLAS PHARMA
  • Hormonal Therapy
  • Chemotherapy
  • Immunotherapy
  • Targeted Therapy
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Have query on this report?

Make an Enquiry
1. Preface
     1.1. Report Scope and Description
     1.2. Research Methodology
          1.2.1. Phase I-Secondary Research
          1.2.2. Phase II-Primary Research
          1.2.3. Phase II-Expert Panel Review
          1.2.4. Assumptions
          1.2.5. Approach Adopted

2. Executive Summarysegment Form
     2.1. Global Prostate Cancer Therapeutics Drugs Market Snapshot
          2.1.1. Global Prostate Cancer Therapeutics Drugs Market By Drug Class,2019
               2.1.1.1.Hormonal Therapy
               2.1.1.2.Chemotherapy
               2.1.1.3.Immunotherapy
               2.1.1.4.Targeted Therapy
          2.1.2. Global Prostate Cancer Therapeutics Drugs Market By Distribution Channel,2019
               2.1.2.1.Hospital Pharmacies
               2.1.2.2.Retail Pharmacies
               2.1.2.3.Online Pharmacies
          2.1.3. Global Prostate Cancer Therapeutics Drugs Market By End-use,2019
          2.1.4. Global Prostate Cancer Therapeutics Drugs Market By Geography,2019

3. Global Prostate Cancer Therapeutics Drugs Market Dynamics
     3.1. Market Overview
     3.2. Market Inclination Insights Analysis
     3.3. Drivers
     3.4. Challenges
     3.5. Future Prospects
     3.6. Impact Analysis of Drivers and Challenges During the Forecast Period, (2020-2028)

4. Global Prostate Cancer Therapeutics Drugs Market Size (US$), By Drug Class, 2018 – 2028 
     4.1. Overview
          4.1.1. Market Share Analysis By Drug Class, 2019 vs.2028
          4.1.2. Attractive Investment Proposition By Drug Class, 2020
     4.2. Global Prostate Cancer Therapeutics Drugs Market Size (US$), By Drug Class, 2018 – 2028

5. Global Prostate Cancer Therapeutics Drugs Market Size (US$), By Distribution Channel, 2018 – 2028 
     5.1. Overview
          5.1.1. Market Share Analysis By Distribution Channel, 2019 vs.2028
          5.1.2. Attractive Investment Proposition By Distribution Channel, 2020
     5.2. Global Prostate Cancer Therapeutics Drugs Market Size (US$), By Distribution Channel, 2018 – 2028

6. Global Prostate Cancer Therapeutics Drugs Market Size (US$), By End-use, 2018 – 2028 
     6.1. Overview
          6.1.1. Market Share Analysis By End-use, 2019 vs.2028
          6.1.2. Attractive Investment Proposition By End-use, 2020
     6.2. Global Prostate Cancer Therapeutics Drugs Market Size (US$), By End-use, 2018 – 2028

7. Global Prostate Cancer Therapeutics Drugs Market Size (US$), By Geography, 2018 – 2028
     7.1. Overview
          7.1.1. Market Share Analysis by Geography, 2019 vs. 2028
          7.1.2. Attractive Investment Proposition by Geography, 2020
     7.2. North America Prostate Cancer Therapeutics Drugs Market Analysis, 2018 – 2028 
          7.2.1. North America Prostate Cancer Therapeutics Drugs Market Size (US$), By Country, 2018 – 2028 
               7.2.1.1. U.S.
               7.2.1.2. Canada
          7.2.2. North America Prostate Cancer Therapeutics Drugs Market Size (US$), By Drug Class, 2018 – 2028
          7.2.3. North America Prostate Cancer Therapeutics Drugs Market Size (US$), By Distribution Channel, 2018 – 2028
          7.2.4. North America Prostate Cancer Therapeutics Drugs Market Size (US$), By End-use, 2018 – 2028
     7.3. Europe Prostate Cancer Therapeutics Drugs Market Analysis, 2018 – 2028 
          7.3.1.  Europe Prostate Cancer Therapeutics Drugs Market Size (US$), By Country, 2018 – 2028 
               7.3.1.1. U.K.
               7.3.1.2. Germany
               7.3.1.3. France
               7.3.1.4. Rest of Europe
          7.3.2. Europe Prostate Cancer Therapeutics Drugs Market Size (US$), By Drug Class, 2018 – 2028
          7.3.3. Europe Prostate Cancer Therapeutics Drugs Market Size (US$), By Distribution Channel, 2018 – 2028
          7.3.4. Europe Prostate Cancer Therapeutics Drugs Market Size (US$), By End-use, 2018 – 2028
     7.4. Asia Pacific Prostate Cancer Therapeutics Drugs Market Analysis , 2018 – 2028
          7.4.1.  Asia Pacific Prostate Cancer Therapeutics Drugs Market Size (US$), By Country, 2018 – 2028 
               7.4.1.1. China
               7.4.1.2. Japan
               7.4.1.3. India
               7.4.1.4. Rest of Asia Pacific
          7.4.2. Asia Pacific Prostate Cancer Therapeutics Drugs Market Size (US$), By Drug Class, 2018 – 2028
          7.4.3. Asia Pacific Prostate Cancer Therapeutics Drugs Market Size (US$), By Distribution Channel, 2018 – 2028
          7.4.4. Asia Pacific Prostate Cancer Therapeutics Drugs Market Size (US$), By End-use, 2018 – 2028
     7.5. Latin America Prostate Cancer Therapeutics Drugs Market Analysis, 2018 – 2028 
          7.5.1.  Latin America Prostate Cancer Therapeutics Drugs Market Size (US$), By Country, 2018 – 2028 
               7.5.1.1. Brazil
               7.5.1.2. Mexico
               7.5.1.3. Rest of Latin America
          7.5.2. Latin America Prostate Cancer Therapeutics Drugs Market Size (US$), By Drug Class, 2018 – 2028
          7.5.3. Latin America Prostate Cancer Therapeutics Drugs Market Size (US$), By Distribution Channel, 2018 – 2028
          7.5.4. Latin America Prostate Cancer Therapeutics Drugs Market Size (US$), By End-use, 2018 – 2028
     7.6. Middle East & Africa (MEA) Prostate Cancer Therapeutics Drugs Market Analysis, 2018 – 2028 
          7.6.1.  MEA Prostate Cancer Therapeutics Drugs Market Size (US$), By Region, 2018 – 2028 
               7.6.1.1. GCC Countries
               7.6.1.2. South Africa
               7.6.1.3. Rest of MEA
          7.6.2. MEA Prostate Cancer Therapeutics Drugs Market Size (US$), By Drug Class, 2018 – 2028
          7.6.3. MEA Prostate Cancer Therapeutics Drugs Market Size (US$), By Distribution Channel, 2018 – 2028
          7.6.4. MEA Prostate Cancer Therapeutics Drugs Market Size (US$), By End-use, 2018 – 2028

8. Company Profiles
     8.1. Competitive Analysis 
     8.2. Market Positioning of Key Vendors 
     8.3. Key Strategies adopted by the Leading Players
     8.4. Key Prostate Cancer Therapeutics Drugs Providers
        8.4.1 JOHNSON AND JOHNSON
                8.4.1.1 Business Description
                8.4.1.2 JOHNSON AND JOHNSON Geographic Operations
                8.4.1.3 JOHNSON AND JOHNSON Financial Information
                8.4.1.4 JOHNSON AND JOHNSON Product Positions/Portfolio
                8.4.1.5 JOHNSON AND JOHNSON Key Developments
        8.4.2 ASTELLA, INC.
                8.4.2.1 Business Description
                8.4.2.2 ASTELLA, INC. Geographic Operations
                8.4.2.3 ASTELLA, INC. Financial Information
                8.4.2.4 ASTELLA, INC. Product Positions/Portfolio
                8.4.2.5 ASTELLA, INC. Key Developments
        8.4.3 SANOFI
                8.4.3.1 Business Description
                8.4.3.2 SANOFI Geographic Operations
                8.4.3.3 SANOFI Financial Information
                8.4.3.4 SANOFI Product Positions/Portfolio
                8.4.3.5 SANOFI Key Developments
        8.4.4 IPSEN
                8.4.4.1 Business Description
                8.4.4.2 IPSEN Geographic Operations
                8.4.4.3 IPSEN Financial Information
                8.4.4.4 IPSEN Product Positions/Portfolio
                8.4.4.5 IPSEN Key Developments
        8.4.5 BAYER AG
                8.4.5.1 Business Description
                8.4.5.2 BAYER AG Geographic Operations
                8.4.5.3 BAYER AG Financial Information
                8.4.5.4 BAYER AG Product Positions/Portfolio
                8.4.5.5 BAYER AG Key Developments
        8.4.6 ASTRAZENECA
                8.4.6.1 Business Description
                8.4.6.2 ASTRAZENECA Geographic Operations
                8.4.6.3 ASTRAZENECA Financial Information
                8.4.6.4 ASTRAZENECA Product Positions/Portfolio
                8.4.6.5 ASTRAZENECA Key Developments
        8.4.7 VALEANT PHARMACEUTICALS NORTH AMERICA LLC (DENDREON CORPORATION)
                8.4.7.1 Business Description
                8.4.7.2 VALEANT PHARMACEUTICALS NORTH AMERICA LLC (DENDREON CORPORATION) Geographic Operations
                8.4.7.3 VALEANT PHARMACEUTICALS NORTH AMERICA LLC (DENDREON CORPORATION) Financial Information
                8.4.7.4 VALEANT PHARMACEUTICALS NORTH AMERICA LLC (DENDREON CORPORATION) Product Positions/Portfolio
                8.4.7.5 VALEANT PHARMACEUTICALS NORTH AMERICA LLC (DENDREON CORPORATION) Key Developments
        8.4.8 TOLMAR INC
                8.4.8.1 Business Description
                8.4.8.2 TOLMAR INC Geographic Operations
                8.4.8.3 TOLMAR INC Financial Information
                8.4.8.4 TOLMAR INC Product Positions/Portfolio
                8.4.8.5 TOLMAR INC Key Developments
        8.4.9 ENDO PHARMACEUTICALS
                8.4.9.1 Business Description
                8.4.9.2 ENDO PHARMACEUTICALS Geographic Operations
                8.4.9.3 ENDO PHARMACEUTICALS Financial Information
                8.4.9.4 ENDO PHARMACEUTICALS Product Positions/Portfolio
                8.4.9.5 ENDO PHARMACEUTICALS Key Developments
        8.4.10 ABBVIE, INC.
                8.4.10.1 Business Description
                8.4.10.2 ABBVIE, INC. Geographic Operations
                8.4.10.3 ABBVIE, INC. Financial Information
                8.4.10.4 ABBVIE, INC. Product Positions/Portfolio
                8.4.10.5 ABBVIE, INC. Key Developments
        8.4.11 BDR Pharma
                8.4.11.1 Business Description
                8.4.11.2 BDR Pharma Geographic Operations
                8.4.11.3 BDR Pharma Financial Information
                8.4.11.4 BDR Pharma Product Positions/Portfolio
                8.4.11.5 BDR Pharma Key Developments
        8.4.12 CADILA HEALTHCARE
                8.4.12.1 Business Description
                8.4.12.2 CADILA HEALTHCARE Geographic Operations
                8.4.12.3 CADILA HEALTHCARE Financial Information
                8.4.12.4 CADILA HEALTHCARE Product Positions/Portfolio
                8.4.12.5 CADILA HEALTHCARE Key Developments
        8.4.13 DR. REDDY'S LABORATORIES
                8.4.13.1 Business Description
                8.4.13.2 DR. REDDY'S LABORATORIES Geographic Operations
                8.4.13.3 DR. REDDY'S LABORATORIES Financial Information
                8.4.13.4 DR. REDDY'S LABORATORIES Product Positions/Portfolio
                8.4.13.5 DR. REDDY'S LABORATORIES Key Developments
        8.4.14 PFIZER
                8.4.14.1 Business Description
                8.4.14.2 PFIZER Geographic Operations
                8.4.14.3 PFIZER Financial Information
                8.4.14.4 PFIZER Product Positions/Portfolio
                8.4.14.5 PFIZER Key Developments
        8.4.15 ASTELLAS PHARMA
                8.4.15.1 Business Description
                8.4.15.2 ASTELLAS PHARMA Geographic Operations
                8.4.15.3 ASTELLAS PHARMA Financial Information
                8.4.15.4 ASTELLAS PHARMA Product Positions/Portfolio
                8.4.15.5 ASTELLAS PHARMA Key Developments

LIST OF TABLES

TABLE 1 Market Snapshot: Global Prostate Cancer Therapeutics Drugs Market 
TABLE 2 Impact Indicators 
TABLE 3 Impact Analysis of Drivers and Restraints 
TABLE 4 North America Prostate Cancer Therapeutics Drugs Market Revenue, By Drug Class, 2018 – 2028 (US$ Mn) 
TABLE 5 North America Prostate Cancer Therapeutics Drugs Market Revenue, By Distribution Channel, 2018 – 2028 (US$ Mn) 
TABLE 6 North America Prostate Cancer Therapeutics Drugs Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 7 Europe Prostate Cancer Therapeutics Drugs Market Revenue, By Drug Class, 2018 – 2028 (US$ Mn) 
TABLE 8 Europe Prostate Cancer Therapeutics Drugs Market Revenue, By Distribution Channel, 2018 – 2028 (US$ Mn) 
TABLE 9 Europe Prostate Cancer Therapeutics Drugs Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 10 Asia Pacific Prostate Cancer Therapeutics Drugs Market Revenue, By Drug Class, 2018 – 2028 (US$ Mn) 
TABLE 11 Asia Pacific Prostate Cancer Therapeutics Drugs Market Revenue, By Distribution Channel, 2018 – 2028 (US$ Mn) 
TABLE 12 Asia Pacific Prostate Cancer Therapeutics Drugs Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 13 Latin America Prostate Cancer Therapeutics Drugs Market Revenue, By Drug Class, 2018 – 2028 (US$ Mn) 
TABLE 14 Latin America Prostate Cancer Therapeutics Drugs Market Revenue, By Distribution Channel, 2018 – 2028 (US$ Mn) 
TABLE 15 Latin America Prostate Cancer Therapeutics Drugs Market Revenue, By End-use, 2018 – 2028 (US$ Mn)
TABLE 16 MEA Prostate Cancer Therapeutics Drugs Market Revenue, By Drug Class, 2018 – 2028 (US$ Mn) 
TABLE 17 MEA Prostate Cancer Therapeutics Drugs Market Revenue, By Distribution Channel, 2018 – 2028 (US$ Mn) 
TABLE 18 MEA Prostate Cancer Therapeutics Drugs Market Revenue, By End-use, 2018 – 2028 (US$ Mn)

LIST OF FIGURES

FIG. 1 Global Prostate Cancer Therapeutics Drugs: Market Segmentation 
FIG. 2 Global Prostate Cancer Therapeutics Drugs Market: Research Methodology 
FIG. 3 Top-Down and Bottom-up Approach 
FIG. 4 Global Prostate Cancer Therapeutics Drugs Market, By Drug Class, 2019 (US$ Mn) 
FIG. 5 Global Prostate Cancer Therapeutics Drugs Market, By Distribution Channel, 2019 (US$ Mn) 
FIG. 6 Global Prostate Cancer Therapeutics Drugs Market, By End-use, 2019 (US$ Mn) 
FIG. 7 Global Prostate Cancer Therapeutics Drugs Market, By Geography, 2019 (US$ Mn) 
FIG. 8 Global Prostate Cancer Therapeutics Drugs Market Revenue and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG. 9 Attractive Investment Proposition 
FIG. 10 Market Positioning of Key Prostate Cancer Therapeutics Drugs Providers, 2019
FIG. 11 Global Prostate Cancer Therapeutics Drugs Market Revenue Contribution, By Drug Class, 2019 & 2028 (Value %) 
FIG. 12 Global Prostate Cancer Therapeutics Drugs Market Revenue Contribution, By Distribution Channel, 2019 & 2028 (Value %) 
FIG. 13 Global Prostate Cancer Therapeutics Drugs Market Revenue Contribution, By End-use, 2019 & 2028 (Value %) 
FIG. 14 North America Prostate Cancer Therapeutics Drugs Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 15 Europe Prostate Cancer Therapeutics Drugs Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 16 Asia Pacific Prostate Cancer Therapeutics Drugs Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 17 Latin America Prostate Cancer Therapeutics Drugs Market Revenue, 2018 – 2028, (US$ Mn)
FIG. 18 MEA Prostate Cancer Therapeutics Drugs Market Revenue, 2018 – 2028, (US$ Mn)

Key Takeaways:

1. Market value and estimate of the Prostate Cancer Therapeutics Drugs market for the period from 2020 to 2028
2. Compounded annual growth rate (CAGR%) for individual segments in various regional markets for a period from 2020 to 2028
3. Value chain analysis
4. Market share study combined with competitive landscape of major players
5. Profiles of major market players covering overall business operations, geographic occurrence, product portfolio, financial status and news coverage 

List of Tables

TABLE  Market Snapshot: Global Prostate Cancer Therapeutics Drugs Market
TABLE  Impact Pointers
TABLE  Impact Analysis of Drivers and Restraints
TABLE  North America Prostate Cancer Therapeutics Drugs Market Value, By Segment1, 2018 – 2028
TABLE  North America Prostate Cancer Therapeutics Drugs Market Value, By Segment2, 2018 – 2028
TABLE  North America Prostate Cancer Therapeutics Drugs Market Value, By Country, 2018 – 2028
TABLE  Europe Prostate Cancer Therapeutics Drugs Market Value, By Segment1, 2018 – 2028
TABLE  Europe Prostate Cancer Therapeutics Drugs Market Value, By Segment2, 2018 – 2028
TABLE  Europe Prostate Cancer Therapeutics Drugs Market Value, By Country, 2018 – 2028
TABLE  Asia Pacific Prostate Cancer Therapeutics Drugs Market Value, By Segment1, 2018 – 2028
TABLE  Asia Pacific Prostate Cancer Therapeutics Drugs Market Value, By Segment2, 2018 – 2028
TABLE  Asia Pacific Prostate Cancer Therapeutics Drugs Market Value, By Country, 2018 – 2028
TABLE  Latin America Prostate Cancer Therapeutics Drugs Market Value, By Segment1, 2018 – 2028
TABLE  Latin America Prostate Cancer Therapeutics Drugs Market Value, By Segment2, 2018 – 2028
TABLE  Latin America Prostate Cancer Therapeutics Drugs Market Value, By Country, 2018 – 2028
TABLE  MEA Prostate Cancer Therapeutics Drugs Market Value, By Segment1, 2018 – 2028
TABLE  MEA Prostate Cancer Therapeutics Drugs Market Value, By Segment2, 2018 – 2028
TABLE  MEA Prostate Cancer Therapeutics Drugs Market Value, By Country, 2018 – 2028
TABLE  JOHNSON AND JOHNSON: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  ASTELLA, INC.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  SANOFI: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  IPSEN: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  BAYER AG: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  ASTRAZENECA: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  VALEANT PHARMACEUTICALS NORTH AMERICA LLC (DENDREON CORPORATION): Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  TOLMAR INC: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  ENDO PHARMACEUTICALS: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  ABBVIE, INC.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  BDR Pharma: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  CADILA HEALTHCARE: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  DR. REDDY'S LABORATORIES: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  PFIZER: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  ASTELLAS PHARMA: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
 

List of Figures

FIG.  Global Prostate Cancer Therapeutics Drugs Market: Research Methodology
FIG.  Top-Down and Bottom Up Approach
FIG.  Global Prostate Cancer Therapeutics Drugs Market, By Segment1, 2019 (US$ Mn)
FIG.  Global Prostate Cancer Therapeutics Drugs Market, By Segment2, 2019 (US$ Mn)
FIG.  Global Prostate Cancer Therapeutics Drugs Market, By Geography, 2019 (US$ Mn)
FIG.  Global Prostate Cancer Therapeutics Drugs Market Value and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG.  Attractive Investment Proposition
FIG.  Market Positioning of Key Prostate Cancer Therapeutics Drugs Providers, 2016
FIG.  Global Prostate Cancer Therapeutics Drugs Market Value Share, By Segment1, 2019 & 2028 (% Value)
FIG.  Global Chemotherapy Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Immunotherapy Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Targeted Therapy Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Prostate Cancer Therapeutics Drugs Market Value Share, By Segment2, 2019 & 2028 (% Value)
FIG.  Global Retail Pharmacies Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Online Pharmacies Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Market Value, 2018 – 2028, (US$ Mn)
FIG.  U.S. Prostate Cancer Therapeutics Drugs Market Value, 2018 – 2028, (US$ Mn)
FIG.  Canada Prostate Cancer Therapeutics Drugs Market Value, 2018 – 2028, (US$ Mn)
FIG.  UK Prostate Cancer Therapeutics Drugs Market Value, 2018 – 2028, (US$ Mn)
FIG.  Germany Prostate Cancer Therapeutics Drugs Market Value, 2018 – 2028, (US$ Mn)
FIG.  France Prostate Cancer Therapeutics Drugs Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Europe Prostate Cancer Therapeutics Drugs Market Value, 2018 – 2028, (US$ Mn)
FIG.  China Prostate Cancer Therapeutics Drugs Market Value, 2018 – 2028, (US$ Mn)
FIG.  Japan Prostate Cancer Therapeutics Drugs Market Value, 2018 – 2028, (US$ Mn)
FIG.  India Prostate Cancer Therapeutics Drugs Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Asia Pacific Prostate Cancer Therapeutics Drugs Market Value, 2018 – 2028, (US$ Mn)
FIG.  Mexico Prostate Cancer Therapeutics Drugs Market Value, 2018 – 2028, (US$ Mn)
FIG.  Brazil Prostate Cancer Therapeutics Drugs Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Latin America Prostate Cancer Therapeutics Drugs Market Value, 2018 – 2028, (US$ Mn)
FIG.  GCC Countries Prostate Cancer Therapeutics Drugs Market Value, 2018 – 2028, (US$ Mn)
FIG.  South Africa Prostate Cancer Therapeutics Drugs Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of MEA Prostate Cancer Therapeutics Drugs Market Value, 2018 – 2028, (US$ Mn)